Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Reversal of Anticoagulation By Ciraparantag: Time to Onset and Duration of Effect

Jack Ansell, MD, Bryan Laulicht, PhD, Sasha Bakhru, PhD, Xiaohui Luo, PhD, Stephen Villano, MD

Blood (2020) 136 (Supplement 1): 24.

https://doi.org/10.1182/blood-2020-140524

Published: 2020

Journal Articles

Ciraparantag Safely and Effectively Reverses Apixaban and Rivaroxaban in Age-Matched Healthy Volunteers As Measured By Whole Blood Clotting Time

Bryan Laulicht, PhD, Sasha Bakhru, PhD, Solomon Steiner, PhD, Jack Ansell, MD

Blood (2018) 132 (Supplement 1): 987.

https://doi.org/10.1182/blood-2018-99-116754

Published: 2018

Journal Articles

Indirect Comparison Of Dabigatran, Rivaroxaban and Apixaban For Venous Thromboembolic Disease

Simon Mantha, MD, MPH, Jack Ansell, MD

Blood (2013) 122 (21): 3640.

https://doi.org/10.1182/blood.V122.21.3640.3640

Published: 2013

Journal Articles

Anticoagulant Management of Atrial Fibrillation In the United States: Findings From a Large National Database of Clinical Test Results (Quest Diagnostics Health Trends™ Report).

Jeffrey S. Dlott, MD, Roberta George, MS, Xiaohua Huang, MS, Muneer Odeh, MS, Harvey W. Kaufman, MD, Elaine M. Hylek, MD, MPH, Jack Ansell, MD

Blood (2010) 116 (21): 1103.

https://doi.org/10.1182/blood.V116.21.1103.1103

Published: 2010

Journal Articles

Indications for Inferior Vena Cava (IVC) Filter Placement - Assessing Compliance with Accepted Standards Set by Two Professional Societies

Amanjit S. Baadh, MD, Stephen Rivoli, MPH, MA, CPHQ, Jack Ansell, MD, Robert E. Graham, MD, MPH

Blood (2010) 116 (21): 2553.

https://doi.org/10.1182/blood.V116.21.2553.2553

Published: 2010

Journal Articles

A Phase II Randomized, Double-Blind, Eight-Arm, Parallel-Group, Dose-Response Study of Apixaban, a New Oral Factor Xa Inhibitor for the Prevention of Deep Vein Thrombosis in Knee Replacement Surgery - On Behalf of the Apixaban Investigators.

Michael R. Lassen, MD, Bruce L. Davidson, MD, Alexander Gallus, MD, Graham Pineo, MD, Jack Ansell, MD, David Deitchman, PhD

Blood (2006) 108 (11): 574.

https://doi.org/10.1182/blood.V108.11.574.574

Published: 2006

Journal Articles

A Randomized, Double-Blind Trial of the Interaction between Cranberry Juice and Warfarin.

Jack Ansell, MD, Maryellen McDonough, RN, Jerold S. Harmatz, David J. Greenblatt, MD

Blood (2006) 108 (11): 4125.

https://doi.org/10.1182/blood.V108.11.4125.4125

Published: 2006

NARROW

Reversal of Anticoagulation By Ciraparantag: Time to Onset and Duration of Effect

Ciraparantag Safely and Effectively Reverses Apixaban and Rivaroxaban in Age-Matched Healthy Volunteers As Measured By Whole Blood Clotting Time

Indirect Comparison Of Dabigatran, Rivaroxaban and Apixaban For Venous Thromboembolic Disease

Anticoagulant Management of Atrial Fibrillation In the United States: Findings From a Large National Database of Clinical Test Results (Quest Diagnostics Health Trends™ Report).

Indications for Inferior Vena Cava (IVC) Filter Placement - Assessing Compliance with Accepted Standards Set by Two Professional Societies

A Phase II Randomized, Double-Blind, Eight-Arm, Parallel-Group, Dose-Response Study of Apixaban, a New Oral Factor Xa Inhibitor for the Prevention of Deep Vein Thrombosis in Knee Replacement Surgery - On Behalf of the Apixaban Investigators.

A Randomized, Double-Blind Trial of the Interaction between Cranberry Juice and Warfarin.

Email alerts

ASH Publications

American Society of Hematology

Reversal of Anticoagulation By Ciraparantag: Time to Onset and Duration of Effect

Ciraparantag Safely and Effectively Reverses Apixaban and Rivaroxaban in Age-Matched Healthy Volunteers As Measured By Whole Blood Clotting Time

Indirect Comparison Of Dabigatran, Rivaroxaban and Apixaban For Venous Thromboembolic Disease

Anticoagulant Management of Atrial Fibrillation In the United States: Findings From a Large National Database of Clinical Test Results (Quest Diagnostics Health Trends™ Report).

Indications for Inferior Vena Cava (IVC) Filter Placement - Assessing Compliance with Accepted Standards Set by Two Professional Societies

A Phase II Randomized, Double-Blind, Eight-Arm, Parallel-Group, Dose-Response Study of Apixaban, a New Oral Factor Xa Inhibitor for the Prevention of Deep Vein Thrombosis in Knee Replacement Surgery - On Behalf of the Apixaban Investigators.

A Randomized, Double-Blind Trial of the Interaction between Cranberry Juice and Warfarin.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only